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Evaluation of 35 cases of polycystic ovarian syndrome that 
treated with cyproterone in Ardabil university of Medical 
Science 
Kahnamoe.F,MD; Panahali.A,MD ; Sadeghieh Ahari.S, MD 
Background and objective: polycyctic ovarian syndrome (PCOS) in one of the 
most common endocrine and genetically disorders in women. This syndrome is 
carcterized by menstrual disturbances, infertility, obesity, hirustism, Acnea, 
Alopecia. So that etiology of PCOS is related to hyper androgenism therefore 
if anti androgenic Drugs such as cyproterone compound to be used in these 
patients with improve symptoms of PCOS. This study evaluated effects 
cyproterone treatment of PCOS patient specially to improve menstrual cycle 
disturbances and also evaluated specific character of PCOS. 
Materials and Methods: This study was case series that our study populations 
(sample) were 35 persons of women with polycystic ovarian syndrome that 
their chief complaints were menstrual cycle disturbance that treated 6 months 
with cyproterone. Data collecting was through medical history taking, physical 
examination from patient file and filling of related questionnaire and we 
evaluated relations between findings by SPSS software. 
Results: Outcomes indicated that mean age of our study patients was 
19.08±2.3 years old, minimum & maximum age was (15-26) years old. 
82.9 percent of our patients (29 persons) were single and 17.11 percent of 
patients (6persons) were married. 
Most patients with frequency of 45.7 percent (16 persons) only have menstrual 
cycle disturbance and don't have other symptoms of PCOS, and hirsutism plus 
Acnea are most common symptom in symptomatic patients with frequency of 
14.3 percent (5persons). 
Oligomenorrhea was most common menstrual cycle disturbance in patients 
with frequency of 31.2 percent (11 persons), and oligomenorrhea plus 
menometrohagea have second degree with frequency of 22.9 percent (8 
persons). 71.4 percent of patients don't have nay aggravating factor for 
menstrual cycle disturbance and 22.8 percent of patients (8persons) say that 
anxiety is aggravating factor. 60percent of patients don't have positive familial 
history of PCOS and from 14 residual patients, 13 cases have positive familial 
history in first degree family. One person have positive familial history in 
second degree family. Average of body mass index (BMI) in patients was 
25.3±2.9 kg/m
2
. Minimum & maximum of BMI was (19-33 kg/m
2
). Mean 
initiate age of patients were 16.3±2.8 years old. Minimum and maximum of 
initiate age was (14-24) years old. From 35 patients of our study , 29 persons 
(82.85 percents) have positive response to treatment with cyproterone 
compound and 6 persons (17.15 percent) stop use of drug to side effects and 
don't have nay treatment failure 
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